Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Videndum says debt discussions progressing positively

(Sharecast News) - Videndum said in an update on Tuesday that its debt discussions were progressing, as it confirmed it would publish its audited results for the year ended 31 December on 30 April. The London-listed film and television equipment and technology specialist said it expected the figures to be in line with the guidance it provided in its trading update on 16 December.

It also confirmed that discussions with its lending banks to reset all future covenants under its revolving credit facility were progressing positively.

The board said the reset was expected to be completed ahead of the end-April deadline.

In parallel, Videndum said it was advancing plans to refinance the facility, which matures in August 2026.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

RBC Capital ups price target on Hikma
(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.
Home Depot won't hike prices in response to tariffs, Q1 sales fall
(Sharecast News) - US do-it-yourself chain Home Depot on Tuesday held full-year sales forecasts and said it did not expect to raise prices in response to President Donald trump's tariffs.
Poolbeg raises nearly £5m to progress clinical trials
(Sharecast News) - Shares in biopharmaceutical group Poolbeg Pharma sank on Tuesday after the company revealed wider losses for the 2024 financial year as it raised nearly £5m in an oversubscribed placing as it progresses two key clinical trials.
Berenberg starts coverage of Accesso Technology at 'buy'
(Sharecast News) - Berenberg initiated coverage of Accesso Technology on Tuesday with a 'buy' rating and 775p price target.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.